RE:RE:RE:New Day - New Shout Out...Eoganacht thanks for another very interesting find...(keep it coming).
When TLT is properly funded, I would also like to see Dr.McFarland new
SUPER PDCs COMPOUND being tested in a trial.
https://theralase.com/theralase-researcher-discovers-super-potent-anti-cancer-drugs/ Question?????? How much $$$$ will a Big Pharma be willing to pay for a PDCs compound 10 billion times more potent than other tested PDCs?
It is easy to hold on to your TLT shares when you know what is coming in the future.
Eoganacht wrote: I think Theralase is ahead. But there could be any number of clinical trials going on I'm not aware of.
A recent Theralase nr reported the destruction of NSCLC in mice using X-ray activated Rutherrin, so Theralase has a solution that works.
But there may be room for improvement. XPDT overcomes the depth of penetration limitation of visible light but the difficulty is how effectively energy can be transferred from the X-Ray to the PS. Dr. McFarland and Lilge published research in 2023 which seeks to solve the problem.
They created a compound composed of a nanoparticle and a Ru-based PS. The X-rays effectively activated the nanoparticles iwhich in turn effectively activated the PS using a process known as
Frster resonance energy transfer. The result is the effective generation of ROS at unlimited tissue penetration depth. (Sounds like the holy grail...)
If Theralase gets properly funded it would be great if they could work on implementing this technology.
High quantum efficiency ruthenium coordination complex photosensitizer for improved radiation-activated Photodynamic Therapy DJDawg wrote:
Great find. One thing that I hope TLT is ahead of is finding and validating an agent that can be activated by xrays. That is a huge thing to have since light can only penetrate mm in tissue.
Eog, would that be correct? xray activation still appears to be an area where TLT is ahead?